Dr. Ross previews Northwestern-led CME series in urologic oncology


This monthly series will begin in January 2024, and attendees can earn one category 1 CME credit per session.

In this video, Ashley Ross, MD, PhD, gives an overview of an upcoming Northwestern University-led continuing medical education (CME) series titled, “Advances and Updates in Urologic Oncology.” Ross is an associate professor at the Northwestern University Feinberg School of Medicine in Chicago, Illinois.

You can learn more about the CME series and view sessions here.

Video Transcript:

Hi, thanks for joining me today. I'm Ashley Ross, I'm an associate professor at Northwestern Feinberg School of Medicine. I'm delighted to talk a little bit about one of our continuing medical education series that we have for urologic cancers. This is a series that we have that is virtual only, so people can join from anywhere around the country. It's not restricted to faculty at Northwestern or even to physicians. So, physicians, advanced providers, such as nurse practitioners, physician assistants, people from medical school, residents, even folks from industry, or ones that want to just know more about different topics can join these. The sessions typically happen on Thursdays at 5:30. People who are physicians can get one category 1 credit through CME. So, I'll just share my screen for a second.

I would direct you to the Polsky Urologic Cancer Institute. The URL is there in the upper left, and we can make it available for you. If you go here and you click on CME, it will take you to this webpage, where you can register. The CME course, when attended in real time, allows for one category 1 AMA credit. But, if you do not make the course and you want to listen online in the future, many of the videos are archived and accessible both on this website and on YouTube. We've had speakers nationally and internationally talk about prostate cancer, bladder cancer, renal cell carcinoma, and other topics. As you can see, the topics range from new updates in the field–things like salvage therapies, PET imaging–highlights from national meetings, and the like.

This session, which will be kicking off next week, will be one where we highlight some of the updates in prostate cancer diagnosis and care from 2023. We take a little bit of a look to the future, so it'll be a nice overview session. Again, there's lots of ways that people can get information, and thankfully, there are some institutions like our own who have avenues in which you can also get continuing medical education credit. It's an easy program. I think the content is very good and rich. I'll be giving the lecture next week. I'd be delighted if you can join us. And thank you very much for the opportunity to highlight this program.

This transcription has been edited for clarity.

Related Videos
Todd M. Morgan, MD, answers a question during a Zoom video interview
DNA strands | Image Credit: ©  Matthieu - stock.adobe.com
Doctor consulting with patient | Image Credit: © Khunatorn - stock.adobe.com
Man talking with doctor | Image Credit: © rocketclips - stock.adobe.com
Keyan Salari, MD, PhD, answers a question during a Zoom video interview
Scott Morgan, MD, MSc, FRCPC, answers a question during a Zoom video interview
Illustration of prostate | Image Credit: © Judith - stock.adobe.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.